The Red Nucleus acquisition strengthens Health Economics and Outcomes Research expertise across the global life sciences market. The company confirmed its plan to acquire Bridge Medical Consulting. In addition, the acquisition seeks to enhance Health Economics and Outcomes Research services for biopharmaceutical companies globally.
Expanding Strategic Consulting Expertise
Red Nucleus offers strategic consulting services in research, medical affairs, and commercial operations. In this phase, the acquisition by Red Nucleus strengthens expertise in the evaluation of specialized therapies. Moreover, the acquisition assists companies in managing reimbursement and regulatory challenges more effectively.
Bridge Medical Consulting Brings Advanced Evidence Solutions
Bridge Medical Consulting, founded in 2011, offers strong experience in evidence synthesis and economic modeling. Furthermore, the consulting firm supports pharmaceutical and biotech firms across Europe and the United States. The company also incorporates artificial intelligence processes to improve decision-making and evidence development workflows.
Enhanced Client Services and Research Capabilities
The merged company will provide enhanced services, such as systematic literature reviews and indirect treatment comparisons. Moreover, clients will have improved access to real-world evidence research and strategic advisory services. As such, customers will benefit from combined evidence planning and advanced statistical analysis support.
Leadership Perspective on the Acquisition
“With payers and regulators imposing unprecedented scrutiny on drug pricing and value, HEOR has become mission-critical for life sciences companies,” said Mike Menta, Chief Executive Officer of Red Nucleus. “This acquisition strengthens our ability to support clients across value, evidence, and market access. Bridge Medical Consulting’s expertise, culture, and forward-looking technology approach make them an exceptional fit for Red Nucleus, and we are excited to welcome their team.”
Bridge Medical Consulting’s Vision After Integration
“By joining Red Nucleus, we can scale our impact and provide clients with broader integrated services,” said Paul Gandhi, Founder and Chief Executive Officer of Bridge Medical Consulting, highlighting long-term collaboration goals.
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
